Make a tax-deductible donation to CHOC to support FBXL4 research sample developments
Coming Soon - Additional Links to important publications and key take-aways from each
"Mutations in FBXL4, Encoding a Mitochondrial Protein, Cause Early-Onset Mitochondrial Encephalomyopathy" [2013]
Original Publication identifying the FBXL4 gene in connection with Mitochondrial Disease
Coauthored by labs from the United States, Germany, Italy, Saudi Arabia, and Austria.
NEW findings in 2023 - Multiple labs across the world individually concluded the mitophagy pathway (BNIP3/NIX) which FBXL4 regulates. Understanding what this gene does is the first step to developing treatment.
Summary article
[2023] A mitochondrial SCF‐FBXL4 ubiquitin E3 ligase complex degrades BNIP3 and NIX to restrain mitophagy and prevent mitochondrial disease
[2023] FBXL4 ubiquitin ligase deficiency promotes mitophagy by elevating NIX levels
Liverpool, UK and Frankfurt, Germany
[2023] FBXL4 suppresses mitophagy by restricting the accumulation of NIX and BNIP3 mitophagy receptors
Australia and United States
[2023] FBXL4 mutations cause excessive mitophagy via BNIP3/BNIP3L accumulation leading to mitochondrial DNA depletion syndrome
Shanghai, China
NEW findings in 2024 - Multiple labs across the world individually concluded the involvement of PPTC7 with FBXL4 processing. PPTC7 opens a new door for potential future treatment of FBXL4.
[2024] A mitophagy sensor PPTC7 controls BNIP3 and NIX degradation to regulate mitochondrial mass
[2024] Dual-localized PPTC7 limits mitophagy through proximal and dynamic interactions with BNIP3 and NIX
Washington University (St. Louis) and University of Texas-Dallas
[2024] PPTC7 acts as an essential co-factor of the SCFFBXL4 ubiquitin ligase complex to restrict BNIP3/BNIP3L-dependent mitophagy
[2024] PPTC7 antagonizes mitophagy by promoting BNIP3 and NIX degradation via SCFFBXL4